Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin

References

• Bystrom LM, Rivella S. Cancer cells with irons in the fire. Free Radic Biol Med. 2015;79:337–342.
   PubMed Web of Science ®Google Scholar
• Forciniti S, Greco L, Grizzi F, et al. Iron metabolism in cancer progression. Int J Mol Sci. 2020;21(6):2257.
   Web of Science ®Google Scholar
• Pietrangelo A. Mechanisms of iron hepatotoxicity. J Hepatol. 2016;65(1):226–227.
   PubMed Web of Science ®Google Scholar
• Aykin-Burns N, Ahmad IM, Zhu Y, et al. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J. 2009;418(1):29–37.
   PubMed Web of Science ®Google Scholar
• Pantopoulos K, Mueller S, Atzberger A, et al. Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J Biol Chem. 1997;272(15):9802–9808.
   PubMed Web of Science ®Google Scholar
• Schoenfeld JD, Sibenaller ZA, Mapuskar KA, et al. O2⋅– and H2O2-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate. Cancer Cell. 2017;31(4):487–500.
   PubMed Web of Science ®Google Scholar
• Du J, Wagner BA, Buettner GR, et al. Role of labile iron in the toxicity of pharmacological ascorbate. Free Radic Biol Med. 2015;84:289–295.
   PubMed Web of Science ®Google Scholar
• Mladěnka P, Macáková K, Filipský T, et al. In vitro analysis of iron chelating activity of flavonoids. J Inorg Biochem. 2011;105(5):693–701.
   PubMed Web of Science ®Google Scholar
• Reyes-Farias M, Carrasco-Pozo C. The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci. 2019;20(13):3177.
   PubMed Web of Science ®Google Scholar
• Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. Biotech. 2013;3(6):439–459.
   Google Scholar
• Vafadar A, Shabaninejad Z, Movahedpour A, et al. Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell Biosci. 2020;10:32.
   PubMed Web of Science ®Google Scholar
• Daniels TR, Delgado T, Rodriguez JA, Helguera G, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006;121(2):144–158.
   PubMed Web of Science ®Google Scholar
• Basuli D, Tesfay L, Deng Z, et al. Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene. 2017;36(29):4089–4099.
   PubMed Web of Science ®Google Scholar
• Daniels TR, Bernabeu E, Rodriguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta. 2012;1820(3):291–317.
   PubMed Web of Science ®Google Scholar
• Pinnix ZK, Miller LD, Wang W, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43r–56r.
   Web of Science ®Google Scholar
• Jeong SM, Hwang S, Seong RH. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation. Biochem Biophys Res Commun. 2016;471(3):373–379.
   PubMed Web of Science ®Google Scholar
• Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–355.
   PubMed Web of Science ®Google Scholar
• Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci. 2016;41(3):274–286.
   PubMed Web of Science ®Google Scholar
• Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann NY Acad Sci. 2004;1012:1–13.
   PubMed Web of Science ®Google Scholar
• Reichert CO, Da CJ, Levy D, et al. Hepcidin: homeostasis and diseases related to iron metabolism. Acta Haematol. 2017;137(4):220–236.
   PubMed Web of Science ®Google Scholar
• Neves JV, Caldas C, Wilson JM, et al. Molecular mechanisms of hepcidin regulation in sea bass (Dicentrarchus labrax). Fish Shellfish Immunol. 2011;31(6):1154–1161.
   PubMed Web of Science ®Google Scholar
• Kovac S, Boser P, Cui Y, et al. Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels. Haematologica. 2016;101(5):e173–e176.
   PubMed Web of Science ®Google Scholar
• Jian J, Yang Q, Shao Y, et al. A link between premenopausal iron deficiency and breast cancer malignancy. Bmc Cancer. 2013;13(1):307.
   PubMedGoogle Scholar
• Toyokuni S. Iron and thiols as two major players in carcinogenesis: friends or foes? Front Pharmacol. 2014;5:200.
   PubMed Web of Science ®Google Scholar
• Dev S, Babitt JL. Overview of iron metabolism in health and disease. Hemodial Int. 2017;21(Suppl 1):S6–S20.
   PubMed Web of Science ®Google Scholar
• Jung M, Mertens C, Tomat E, et al. Iron as a central player and promising target in cancer progression. Int J Mol Sci. 2019;20(2):273.
   PubMed Web of Science ®Google Scholar
• Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108(9):3204–3209.
   PubMed Web of Science ®Google Scholar
• Freitas I, Boncompagni E, Vaccarone R, et al. Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement. Anticancer Res. 2007;27(5A):3059–3065.
   PubMed Web of Science ®Google Scholar
• Greene CJ, Attwood K, Sharma NJ, et al. Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients. Oncotarget. 2017;8(63):107052–107075.
   PubMedGoogle Scholar
• Jeong SM, Lee J, Finley LW, et al. SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1. Oncogene. 2015;34(16):2115–2124.
   PubMed Web of Science ®Google Scholar
• Xue X, Ramakrishnan SK, Weisz K, et al. Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab. 2016;24(3):447–461.
   PubMed Web of Science ®Google Scholar
• Jian J, Yang Q, Huang X. Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival. J Biol Chem. 2011;286(41):35708–35715.
   PubMed Web of Science ®Google Scholar
• Jiang XP, Elliott RL, Head JF. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. Anticancer Res. 2010;30(3):759–765.
   PubMed Web of Science ®Google Scholar
• Donovan A, Lima CA, Pinkus JL, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191–200.
   PubMed Web of Science ®Google Scholar
• Ward DG, Roberts K, Brookes MJ, et al. Increased hepcidin expression in colorectal carcinogenesis. World J Gastroenterol. 2008;14(9):1339–1345.
   PubMed Web of Science ®Google Scholar
• Xue D, Zhou C, Shi Y, et al. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin. Oncotarget. 2016;7(48):78804–78812.
   PubMedGoogle Scholar
• Sasu BJ, Li H, Rose MJ, et al. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol Dis. 2010;45(3):238–245.
   PubMed Web of Science ®Google Scholar
• Buss JL, Torti FM, Torti SV. The role of iron chelation in cancer therapy. Curr Med Chem. 2003;10(12):1021–1034.
   PubMed Web of Science ®Google Scholar
• Kalpatthi R, Peters B, Kane I, et al. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010;55(7):1338–1342.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang J, Wang Y, et al. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Int J Pharm. 2017;523(1):300–309.
   PubMed Web of Science ®Google Scholar
• Park C, So HS, Shin CH, et al. Quercetin protects the hydrogen peroxide-induced apoptosis via inhibition of mitochondrial dysfunction in H9c2 cardiomyoblast cells. Biochem Pharmacol. 2003;66(7):1287–1295.
   PubMed Web of Science ®Google Scholar
• Xiao L, Luo G, Tang Y, et al. Quercetin and iron metabolism: what we know and what we need to know. Food Chem Toxicol. 2018;114:190–203.
   PubMed Web of Science ®Google Scholar
• Cheng IF, Breen K. On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex. Biometals. 2000;13(1):77–83.
   PubMed Web of Science ®Google Scholar
• Guo M, Perez C, Wei Y, et al. Iron-binding properties of plant phenolics and cranberry’s bio-effects. Dalton Trans. 2007;2007(43):4951–4961.
   Google Scholar
• van Acker SA, van den Berg DJ, Tromp MN, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med. 1996;20(3):331–342.
   PubMed Web of Science ®Google Scholar
• Najafi M, Tavakol S, Zarrabi A, et al. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Arch Physiol Biochem. 2020;2020:1–15.
   Web of Science ®Google Scholar
• Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys. 2009;53(2):75–100.
   PubMed Web of Science ®Google Scholar
• Lesjak M, Hoque R, Balesaria S, et al. Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro. PLoS One. 2014;9(7):e102900.
   PubMed Web of Science ®Google Scholar
• Guo X, Chen M, Zeng H, et al. Quercetin attenuates ethanol-induced iron uptake and myocardial injury by regulating the angiotensin II-L-type calcium channel. Mol Nutr Food Res. 2018;62(5):e0772.
   Web of Science ®Google Scholar
• Zhen AW, Nguyen NH, Gibert Y, et al. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology. 2013;58(4):1315–1325.
   PubMed Web of Science ®Google Scholar
• Mu M, An P, Wu Q, et al. The dietary flavonoid myricetin regulates iron homeostasis by suppressing hepcidin expression. J Nutr Biochem. 2016;30:53–61.
   PubMed Web of Science ®Google Scholar
• Baccan MM, Chiarelli-Neto O, Pereira RM, et al. Quercetin as a shuttle for labile iron. J Inorg Biochem. 2012;107(1):34–39.
   PubMed Web of Science ®Google Scholar
• Tang Y, Li Y, Yu H, et al. Quercetin attenuates chronic ethanol hepatotoxicity: implication of “free” iron uptake and release. Food Chem Toxicol. 2014;67:131–138.
   PubMed Web of Science ®Google Scholar
• El-Sheikh AA, Ameen SH, AbdEl-Fatah SS. Ameliorating iron overload in intestinal tissue of adult male rats: quercetin vs deferoxamine. J Toxicol. 2018;2018:8023840.
   PubMed Web of Science ®Google Scholar
• Kasiri N, Rahmati M, Ahmadi L, et al. Therapeutic potential of quercetin on human breast cancer in different dimensions. Inflammopharmacology. 2020;28(1):39–62.
   PubMed Web of Science ®Google Scholar
• Tang SM, Deng XT, Zhou J, et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604.
   PubMed Web of Science ®Google Scholar
• Alugoju P, Periyasamy L, Dyavaiah M. Quercetin enhances stress resistance in Saccharomyces cerevisiae tel1 mutant cells to different stressors. J Food Sci Technol. 2018;55(4):1455–1466.
   PubMed Web of Science ®Google Scholar
• Triantafyllou A, Liakos P, Tsakalof A, et al. The flavonoid quercetin induces hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits cell proliferation by depleting intracellular iron. Free Radic Res. 2007;41(3):342–356.
   PubMed Web of Science ®Google Scholar
• Horniblow RD, Henesy D, Iqbal TH, et al. Modulation of iron transport, metabolism and reactive oxygen status by quercetin-iron complexes in vitro. Mol Nutr Food Res. 2017;61(3):e0692.
   Web of Science ®Google Scholar
• Miyazawa M, Bogdan AR, Tsuji Y. Perturbation of iron metabolism by cisplatin through inhibition of iron regulatory protein 2. Cell Chem Biol. 2019;26(1):85–97.
   PubMed Web of Science ®Google Scholar
• Orsolic N, Odeh D, Jembrek MJ, et al. Interactions between cisplatin and quercetin at physiological and hyperthermic conditions on cancer cells in vitro and in vivo. Molecules. 2020;25(14):3271.
   Web of Science ®Google Scholar